TCM
VYNT

Timpani Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Timpani Capital Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,313
Closed -$2.97M – 95
2014
Q1 		$2.97M Sell
1,313
-64
-5% -$164K 1.57% 20
2013
Q4 		$2.85M Buy
1,377
+511
+59% +$1.1M 1.42% 31
2013
Q3 		$2.63M Buy
+866
New +$1.48M 1.55% 24

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $223M AUM 17.15% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Timpani Capital Management's VYNT Position: Q2 2014 in Review

Timpani Capital Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2014, closing a stake of 1,313 shares — an estimated $2.97M sold.

Timpani Capital Management first reported a position in VYNT in Q3 2013 and held it in 3 quarters. The position peaked at $2.97M in Q1 2014. 34 funds tracked by Wall St. Rank hold VYNT as of Q2 2014.

  • Timpani Capital Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Timpani Capital Management sold 1,313 Vyant Bio, Inc. Common Stock shares in Q2 2014, an estimated $2.97M.
  • Timpani Capital Management first reported a position in Vyant Bio, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • Timpani Capital Management's Vyant Bio, Inc. Common Stock position peaked at $2.97M in Q1 2014.
  • 34 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2014.

Based on Timpani Capital Management's 13F filing for Q2 2014, filed 5 Aug 2014.